Who We Are:
Cogent Biosciences is a publicly traded biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has exhibited promising initial data across all three trials: APEX in AdvSM, SUMMIT in NonAdvSM and PEAK in GIST, including an encouraging safety profile across 600+ patients in single agent and combination dosing.
The Role:
This critical role will manage the tactical execution of marketing operations supporting the launch of bezuclastinib, Cogent Biosciences’ key pipeline asset. This role ensures compliant, efficient, and impactful delivery of promotional content, omnichannel campaigns, key marketing KPI’s. This role is critical to implementing. evolving and advancing our organization’s omnichannel capabilities. The Senior Manager partners closely with brand leads to unify personal and non-personal promotional activities into a seamless customer experience that drives brand performance goals and commercial growth.
Responsibilities:
- Omnichannel Campaign Orchestration
- Work with marketing to ensure the execution of complex customer engagement plans into high-performing omnichannel campaigns across HCP, patient, and caregiver audiences.
- Collaborate with analytics teams to integrate insights into campaign design and optimization.
- Ensure systems and platforms readiness to track key data and metrics for campaign effectiveness and measurement.
- Ensure personalization and precision in outreach, leveraging data and segmentation strategies.
- Promotional Review & Content Approval
- Manage the Cogent internal promotional review process (MLR) and understand the end-to-end content approval process for key commercial materials.
- Ensure timely and compliant review of promotional materials, including HCP and patient-facing assets.
- Understand the critical systems supporting these processes such as Veeva Vault PromoMats and ensure system optimization for content approval workflows.
- Agency & Vendor Management
- Assist in agency selection, onboarding, performance tracking, and contract alignment.
- Establish KPIs and ensure high-quality deliverables that support brand objectives and scientific integrity.
- Governance
- Maintain SOPs and process documentation tailored to the key indications for bezuclastinib marketing operations
Qualifications:
- Bachelor’s degree in Marketing, Business, Life Sciences, or related field; advanced degree preferred.
- 4-5+ years of experience in pharmaceutical or biotech industry, with significant experience in oncology and/or rare diseases preferred.
- 3+ years of developing, accelerating and standardizing omnichannel operations processes aligned with the wider omnichannel vision
- Proven leadership in promotional review, omnichannel execution, and vendor management.
- Deep understanding of regulatory requirements, including FDA, PAAB, and global compliance standards.
- Strong business acumen with experience translating strategic priorities into operational execution.
- Experience with key systems and platforms such as Veeva Vault PromoMats and Events highly preferred.
- Strong analytical, communication, and cross-functional collaboration skills.
- Ability to thrive in a fast-paced, high-stakes environment with multiple priorities.
Salary Range:
$175,000 - $200,000 USD
Waltham, MA: Our headquarters is located in the Greater Boston life sciences community, with an open, collaborative office environment designed to support teamwork and connection. Employees benefit from convenient on-site amenities, including free on-site parking and gym facilities in the building.
Boulder, CO: Our Boulder location is home to Cogent’s discovery research organization and a key scientific hub with strong leadership based on site. Situated in the greater Denver-Boulder biopharmaceutical corridor, this office plays a central role in advancing our discovery efforts and pipeline.
Our Offer To You
At Cogent Biosciences, we offer a competitive salary, bonus, and ongoing stock awards, alongside a benefits package that sets us apart. We cover 100% of medical, dental, and vision premiums for you and your family, and help reduce out-of-pocket costs by funding up to 75% of in-network deductibles. Our benefits also include a 401(k) match with immediate vesting, generous paid time off, 12 weeks of fully paid parental leave, paid family and medical leave for all employees regardless of location, and company-paid short-term disability coverage for up to 20 weeks. Additional perks like wellness programs, tuition reimbursement, and inclusive family-forming support help you thrive at work and beyond.
We are proud to be an Equal Opportunity Employer. Our goal is to have a diverse workforce. We do not discriminate on the basis of race, age, color, religion, national origin, gender, sexual orientation, gender identity or expression, veteran status or disability, or any other status protected under federal, state, or local law. All employment is decided on the basis of qualifications, merit, and business need.
Skills Required
- Bachelor's degree in Marketing, Business, Life Sciences or related field
- 4-5+ years experience in pharmaceutical or biotech industry
- 3+ years of developing omnichannel operations processes
- Proven leadership in promotional review, omnichannel execution, and vendor management
- Deep understanding of regulatory requirements including FDA and global compliance standards
- Experience with Veeva Vault PromoMats and Events
What We Do
Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on rational drug discovery and development, we are leveraging validated biology to advance precision therapies designed to address the true underlying drivers of disease and provide real hope for patients. Cogent’s lead therapeutic candidate, bezuclastinib (CGT9486), is a precision kinase inhibitor designed to selectively and potently inhibit the KIT D816V mutation. This mutation is responsible for driving a rare and serious condition called Systemic Mastocytosis which can severely impact many different tissues and organs in the body. We are also studying CGT9486 to treat advanced gastrointestinal stromal tumors (GIST), which have a strong dependence on oncogenic KIT signaling.
